Skip to main content
. 2018 Jul 19;103(12):2033–2039. doi: 10.3324/haematol.2018.198614

Figure 2.

Figure 2.

Event-free survival, cumulative incidence of relapse and overall survival in patients with standard-risk acute promyelocytic leukemia. ARAC: cytarabine; ATO: arsenic trioxide; ATRA: all-trans retinoic acid; CR: complete remission.